Abstract
Lung cancer is rapidly fatal in all but a small minority of patients regardless of therapy [1]. This situation reflects our inability to detect this disease prior to systemic dissemination, and the inadequacy of our systemic therapies for this disease [2]. The enormous investment of the National Cancer Institute and others in empiric new drug development has not had the same impact in lung cancer and other solid tumors as was seen in the hematologic malignancies. Both in response to the unfulfilling drug screening experience and to enhance understanding of tumor biology, many investigators are looking to more rationally developed anticancer therapies to lead to breakthroughs in the control of solid tumors. In lung cancer biology, there are many different directions that could be explored [3]. Recent developments in growth factor biology and the availability of specific antagonists that can be administered to patients, as is the case with monoclonal antibody [4], make this area especially promising. In this chapter we will review the development of growth factor research, attempting to summarize the current state of understanding of the role of growth factors especially as they relate to lung cancer, and discuss how that knowledge can be exploited for the successful therapy of lung cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Minna JD, Higgins GA, Glatstein EJ: Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg S (eds): Principles and Practice of Oncology. Philadelphia, J.B. Lippincott Company, 1985, pp 507–599.
Mulshine J, Glatstein E, Ruckdeschel JC: Treatment of non-small cell lung cancer. J Clin Oncol 4:1704–1715, 1986.
Minna JD, Cuttitta F, Battey J, Mulshine JL, Linnoila I, Gazdar AF, Trepel J, Sausville EA: Autocrine growth factors including gastrin releasing peptide (bombesin) as targets in the pathogenesis and treatment of lung cancer. In: DeVita V, Hellman S, Rosenberg S (eds): Important Advances in Oncology. Philadelphia J.B. Lippincott Co., 1988, pp 55–64.
Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823–826, 1985.
Hayashi I, Sato GH: Replacement of serum by hormones permits growth of cells in a defined medium. Nature (Lond) 259:132–143, 1976.
Simms E, Gazdar AF, Abrams PG, Minna JD: Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res 40:4356–4363, 1980.
Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913–2923, 1985.
Gazdar AF, Carney DN, Nau MM, Minna JD: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45:2924–2930, 1985.
Anatasi A, Erspamer V, Bucci M: Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166, 1971.
Spindel ER, Chin WW, Price, J, Rees LH, Habener JF: Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci USA 81:5699–5703, 1984.
Sausville EA, Lebacq-Verheyden AM, Spindel ER, Cuttitta F, Gazdar AF, Battey JF: Expression of the gastrin-releasing peptide gene in human small cell lung cancer. J Biol Chem 261:2451–2457, 1986.
Wharton J, Polak JM, Bloom SR, Ghatei MA, Solcia E, Brown MR, Pearse AG: Bombesin-like immunoreactivity in the lung. Nature 273:769–770, 1978.
Yamaguchi K, Abe K, Kameya T, Adachi I, Taguchi S, Otsubo K, Yanaihara N: Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 43:3932–3939, 1983.
Ghatei MA, Sheppard MN, Henzen-Logman S, Blank MA, Polak JM, Bloom SR: Bombesin and vasoactive intestinal peptide in the developing lung: marked changes in acute respiratory distress syndrome. J Clin Endocrinol Metab 57:1226–1232, 1983.
Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JD: High levels of intracellular bombesin characterize human small cell lung carcinoma. Science 214:1246–1248, 1981.
Moody TW, Russell EK, O’Donohue TL, Linden CD, Gazdar AF: Bombesin-like peptides in small cell lung cancer: Biochemical characterization and secretion from a cell line. Life Sciences 32:487–493, 1983.
Carney DN, Cuttitta F, Moody TW, Minna JD: Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res 47:821–825, 1987.
Weber S, Zuckerman JE, Bostwick DG, Bensch KG, Sikic BI, Raffin TA: Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest 75:306–309, 1985.
Sporn MB, Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878–880, 1980.
Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Cancer Surv 4:707–727, 1985.
Corps AN, Rees JH, Brown KD: A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin. Biochem J 231:781–784, 1985.
Lehy T, Accary JP, Labeille D, Dubrasquet M: Chronic administration of bombesin stimulates antral gastrin cell proliferation in the rat. Gastroenterology 84:914–919, 1983.
Mendoza SA, Schneider JA, Lopez-Rivas A, Sinnett-Smith JW, Rozengurt E: Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. Changes in Na+ and Ca2+ fluxes, Na+/K+ pump activity and intracellular pH. J Cell Biol 102:2223–2233, 1986.
Rozengurt E, Sinnett-Smith J: Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci USA 80:2936–2940.
Westendorf JM, Schonbrunn A: Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture. Endocrinol 110:352–358, 1982.
Willey JC, Lechner JR, Harris CC: Bombesin and the C-terminal tetradecapeptides of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 153:245–248, 1984.
Heikkila R, Trepel JB, Cuttitta F, Neckers LM, Sausville EA: Bombesin-related peptides induce calcium mobilization in a subset of human small cell lung cancer cell lines. J Biol Chem 262:16456–16460, 1987.
Zachary I, Sinnett-Smith JW, Rozengurt E: Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 102:2211–2222, 1986.
Cirillo DM, Gaudino G, Naldini L, Comoglio PM: Receptor for bombesin with associated tyrosine kinase activity. Mol Cell Biol 6:4641–4649, 1986.
Giraud AS, Soil AH, Cuttitta F, Walsh JH: Bombesin stimulation of gastrin release from canine gastrin cells in primary culture. Am J Physiol 252:G413–G420, 1987.
Woll PJ, Rozengurt E: [D-Arg1,D-Phe5,D-Trp7,9, Leu11] substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell cancer cells’ in vitro. Proc Natl Acad Sci USA 85:1859–1863, 1988.
Alexander RW, Upp JR, Poston GJ, Gupta V, Townsend CM Jr, Thompson JC: Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res 48:1439–1441, 1988.
Trepel JB, Moyer JD, Heikkila R, Sausville EA: Modulation of bombesin-induced phos-phatidylinositol hydrolysis in a small cell lung-cancer cell line. J Bid Chem 262:16456–16460, 1987.
Gaudino G, Cirillo D, Naldine L, Rossino P, Comoglio PM: Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas. Proc Natl Acad Sci USA 85:2166–2170, 1988.
Mulshine JL, Kasprzyk PG, Nakanishi Y, Avis I, Seifter EJ, Cuttitta F: Some considerations for the therapeutic use of monoclonal antibodies in lung cancer. Lung Cancer 4:81–83, 1988.
Mulshine J, Cuttitta F, Avis I, Treston A, Kasprzyk P, Carrasquillo J, Larson S, Walsh T, Merchant B, Minna J: Phase I evaluation of an anti-gastrin releasing peptide GRP monoclonal antibody (MoAb) in patients with advanced lung cancer. Proc Am Soc Clin Oncol 7:231, 1988.
Mulshine JL, Cuttitta F, Avis I, Kasprzyk PG, Treston AM, Nakanishi Y, Weinstein J, Carrasquillo JA, Gazdar AF, Minna JD, Merchant B: Immunologic blockade of autocrine stimulation of lung cancer by gastrin releasing peptide (GRP): A new therapeutic approach. Regulatory Peptides 19:129, 1987.
Mulshine J, Avis I, Treston AM, Kasprzyk PG, Nakanishi Y, Mobley C, Carrasquillo JA, Larson SM, Merchant B, Cuttitta F: In vivo diagnosis and therapy of human tumor with monoclonal antibodies. Nucl Med Biol, in press.
Avis I, Covacs T, Treston AM, Kasprzyk PG, Nakanishi Y, Weinstein J, Walsh J, Batholomew R, Cuttitta F, Mulshine J: Preclinical evaluation of an anti-gastrin releasing peptide (GRP) monoclonal antibody (MoAb) to treat patients with advanced lung cancer. Proc Am Assoc Cancer Res 29:494, 1988.
Moody TW, Carney DN, Cuttitta F, Quattocchi K, Minna JD: High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sciences 37:105–113, 1985.
Kasprzyk PG, Cuttitta F, Avis I, Nakanishi Y, Treston A, Wong H, Walsh JH, Mulshine JL: Solid phase peptide quantitation assay using labelled monoclonal antibody and glu-teraldehyde fixation. Anal Biochem 174:224–234, 1988.
Trepel JB, Moyer JD, Cuttitta F, Frucht H, Coy DH, Natale RB, Mulshine JL, Jensen RT, Sausville EA: A novel bombesin receptor antagonist inhibits autocrine growth signals in a small cell lung carcinoma cell line. Biochem Biophys Res Comm 156:1383–1389, 1988.
Nakanishi Y, Mulshine J, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F: Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82:354–359, 1988.
Macauly VM, Teale JD, Everard MJ, Joshi GP, Smith IE, Millar JL: Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer. Br J Cancer 57:91–93, 1988.
Minuto F, Del Monte P, Barreca A, Alama A, Cariola G, Giordano G: Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Cancer Res 48:3716–3719, 1988.
Gazdar AF, Carney DN: Endocrine properties of small cell carcinoma of the lung. In: Becker KL, Gazdar AF (eds): The Endocrine Lung in Health and Disease. Philadelphia, W.V. Saunders Co., 1984, pp 501–508.
Cuttitta F, Levitt ML, Park JG, Kasprzyk P, Nakanishi Y, Reeve J, Walsh J, Mulshine J, Gazdar AF, Minna JD: Growth of human cancer cell lines in unsupplemented basal media as a means of identifying autocrine growth factors. Proc Am Assoc Cancer Res 28:27, 1987.
Nakanishi Y, Cuttitta F, Kasprzyk PG, Treston AM, Avis I, Minna JD, Kleinman HK, Mulshine JL: The effects of growth factors on the in vitro growth of small cell lung cancer as determined in a colorimetric assay. In: Rosen ST, Mulshine JL, Cuttitta F, Abrams PG (eds): The Biology of Lung Cancer. New York. Marcel Dekker, 1988, pp 59–89.
Van Wyk JJ, Underwood LE, Baseman JB, Hintz RL, Clemmons DR, Marshall RN: Explorations of the insulin-like and growth-promoting properties of somatomedin by membrane receptor assays. Adv Metab Disord 8:127–150, 1975.
Flier JS, Usher P, Moses AC: Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664–668, 1986.
Jonas HA, Harrison CL: The human placenta contains two distincts binding and immuno-reactive species of insulin-like growth factor-I receptors. J Biol Chem 260:2288–2294, 1985.
Jansen MM, van Schaik FM, Ricker AT, Bullock B, Woods DE, Gabbay KH, Nussbaum AL, Sussenbach JS, Van den Brande JL: Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (Lond) 306:609–611, 1983.
Natale RB, Cuttitta F, Nakanishi Y, Minna J, Gazdar AF, Mulshine J: IGF-I can stimulate proliferation of non-small cell lung cancer cell lines in vitro. Proc Am Soc Clin Oncol 7:197, 1988.
Nakanishi Y, Cuttitta F, Kasprzyk PG, Avis I, Steinberg SM, Gazdar AF, Mulshine JL: Growth factor effects on small cell lung cancer cells using a colorimetric assay: Can a transferrin-like factor mediate autocrine growth? Expl Cell Biol 56:74–85, 1988.
Vostrejs M, Moran PL, Seligman PA: Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. J Clin Invest 82:331–339, 1988.
Trowbridge IS, Lopez F: Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. Proc Natl Acad Sci USA 79:1175, 1982.
Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J: Growth stimulation of A431 cells by EGF: Identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci USA 80:1337–1341, 1983.
Masui H, Kawamoto T, Sato JD, Wolf B, Sato GH, Mendelsohn J: Growth inhibition of human tumor cells in athymic mice by anti-EGF receptor monoclonal antibodies. Cancer Res 44:1002–1007, 1984.
Thompson DM, Gill GM: The EGF receptor: structure, regulation, and potential role in malignancy. Cancer Surv 4:767–788, 1985.
Masui H, Moryama T, Mendelsohn J: Mechanism of antitumor activity in mice for anti-EGF receptor monoclonal antibodies with different isotypes. Cancer Res 46:5592–5598, 1986.
Stoscheck CM, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030–1037, 1986.
Carpenter G, Cohen S: Epidermal growth factor. Ann Rev Biochem 48:193–216, 1979.
Goldenberg A, Masui H, Mendelsohn J: EGF receptor (EGFR) overexpression and tumor localization with indium-labeled anti-EGFR MAB. Proc Am Assoc Cancer Res 29:436, 1988.
Yamaguchi K, Miyako Y, Imanishi K, Maruno K, Shimosato Y, Abe K: Lung cancer and autocrine growth factors. Lung Cancer (Suppl) 4:28, 1988.
Sorenson GD, Pettengill OS, Brinck-Johnsen T, Cate CC, Maurer LH: Hormone production by cultures of small-cell carcinoma of the lung. Cancer 47:1289–1296, 1981.
Tatemoto K, Mutt V: Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285:417–418, 1980.
Reeve JR, Cuttitta F, Virga SR, Heubner V, Lee TD, Shively JE, Ho SJ, Fedorko J, Walsh JE: Multiple gastrin releasing peptide gene associated peptides are produced by a human small cell lung cancer line. J Biol Chem 263:1928–1932, 1989.
Tatemoto K, Rokaeus A, Jornvall H, McDonal TJ, Mutt V: Galanin—a nvoel biologically active peptide from porcine intestine. FEBS Letters 164:124–128, 1983.
Tatemoto K, Mutt V: Chemical determination of polypeptide hormones. Proc Natl Acad Sci USA 75:4115–4119, 1978.
Tatemoto K, Carlquist M, Mutt V: Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659–660, 1982.
Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD: Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476–478, 1986.
Treston AM, Yergey A, Kasprzyk PG, Cuttitta F, Mulshine JL: Application of mass spectrometry to the identification of novel peptide hormones involved with lung cancer biology. In: Rosen ST, Mulshine JL, Cuttitta F, Abrams PG (eds): The Biology of Lung Cancer, New York, Marcel Dekker, 1988, pp 91–119.
Treston AM, Kasprzyk PG, Covey T, Lee ED, Henion J, Yergey A, Cuttitta F, Mulshine JL: Thermospray LC/MS of α-carboxyamido amino acids and peptides. Proc Am Soc Mass Spec, 36:1077–1078, 1988.
Lynch SE, Nixon JC, Colvin RB, Antoniades HN: Role of platelet-derived growth factors in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci USA 84:7696–7700, 1987.
Cuttitta F, Fedorko J, Gu J, Lebacq-Verheyden AM, Linnoila RI, Battey J: Gastrin releasing peptide gene associated (GGAPs) are expressed in normal human fetal lung and small cell lung cancer: a novel peptide family found in man. J Clin Endocrinol Metab 67:579–583, 1988.
Mulshine JL: Therapeutic applications of growth factors. Lung Cancer 4:P29, 1988.
Aguayo SM, Kane M, Schwarz MI, King T, Grauer L, Dienhart D, Bunn PA, Miller YE: Bombesin-like immunoreactivity in bronchoalveolar lavage from smokers and interstitial lung disease. Clin Res 35:530A, 1987.
Gaffney M, Altshuler B: Examination of the role of cigarette smoke in lung carcinogenesis using multistage models. J Natl Cancer Inst 80:925–931, 1988.
Tockman MS, Gupta PK, Myers JD, Frost JK, Baylin SB, Gold EB, Chase AM, Wilkinson PH, Mulshine BS, Mulshine JL: Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells. A new approach to early lung cancer detection. J Clin Oncol, 6:1685–1693, 1988.
Frost JK, Fontana RS, Melamed MR: Early lung cancer detection: summary and conclusions. Am Rev Respir Dis 130:565–570, 1984.
Mulshine JL, Cuttitta F, Bibro M, Fedorko J, Fargion S, Little C, Carney DN, Gazdar AF, Minna JD: Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J Immunol 131:497–502, 1983.
Rosen ST, Mulshine JL, Cuttitta F, Fedorko J, Carney DN, Gazdar AF, Minna JD: Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res 44:2052–2061, 1984.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Mulshine, J.L. et al. (1989). Autocrine Growth Factors and Lung Cancer. In: Hansen, H.H. (eds) Basic and Clinical Concepts of Lung Cancer. Cancer Treatment and Research, vol 45. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1593-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1593-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8882-4
Online ISBN: 978-1-4613-1593-3
eBook Packages: Springer Book Archive